ResMed Inc. (RMD)
Last Price$233.1(0.2%)
Market Cap$34.6B
RMD Rating
RMD Quality rating performance
RMD Intrinsic Value
Key Highlights:
As of Mar 03, 2025 RMD Relative Value is $239.8, which is undervalued by 2.9%, compared to current share price of $233.1.
As of Mar 03, 2025 RMD DCF Value is $145.9, which is overvalued by 37.4%, compared to current share price of $233.1.
RMD Share Price History
1W 1.5%
1M (3.1%)
6M (4.6%)
YTD 37.0%
1Y 29.9%
3Y (4.4%)
5Y 46.8%
10Y 309.4%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
RMD Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$34.6B
$35.0B
$4,926.8M
$1,388.4M
Shares Outstanding
149M
Employees
N/A
Growth (CAGR)
12.1%
19.3%
4.92%
27.0%
35.37%
Profitability
57.9%
31.7%
25.3%
30.0%
28.2%
111.2%
Intrinsic Value
$190.6 (18.2% overvalued)
$144.6
$236.5
$194.3
$146.5
49.1%
Return on Capital
Financial Health
$317.8M
0.2x
72.6x
16.0%
Dividends
6.8%
0.9%
21.4%
Nov 07, 2024
Earnings
Apr 23, 2025
BEAT by 3.2%
BEAT by 7.3%
(3.9%)
8 Beat & 2 Miss
RMD Stock Financials
RMD Income Statement Metrics
Annual
Quarterly
LTM
RMD Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$1,401.3M +102.1% YoY
Capital Expenditure (CAPEX)
($114.9M) -14.3% YoY
Free Cash Flow (FCF)
$1,286.4M +130.0% YoY
RMD Income Statement Overview
Annual
Quarterly
LTM
Jun'15
Jun'16
Jun'17
Jun'18
Jun'19
Jun'20
Jun'21
Jun'22
Jun'23
Jun'24
$4,685.3M 10.9% YoY
Cost of revenue
$2,030.0M 8.7% YoY
Pre-tax income
$1,264.8M 14.8% YoY
27.0% margin
RMD Balance Sheet Overview
Annual
Quarterly
LTM
Jun'15
Jun'16
Jun'17
Jun'18
Jun'19
Jun'20
Jun'21
Jun'22
Jun'23
Jun'24
Assets
Liabilities
Total assets
$6,872.4M
Current assets ($2,357.7M, 34.3% of total)
$238.4M (3.5%)
$837.3M (12.2%)
Other current assets
$1,282.1M (18.7%)
Non-current assets ($4,514.7M, 65.7% of total)
$169.8M (2.5%)
$699.1M (10.2%)
$485.9M (7.1%)
Other non-current assets
$3,159.9M (46.0%)
Financial position
$660.9M
Cash & Short-term
Investments
Total Debt
RMD Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
RMD Earnings Surprises
Crunching data... Almost there!
RMD Dividends
RMD Dividend Yield
Crunching data... Almost there!
RMD Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with RMD
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$34.6B | 7.6 | $190.6 18.2% overvalued | 29.9% | $4,926.8M | $1,388.4M | 12.9% | 28.2% | 57.9% | 32.9% | 16.0% | |
$207.3B | 6.9 | $106.1 81.3% overvalued | 41.5% | $8,352.1M | $1,077.2M | 17.2% | 12.9% | 67.5% | 26.8% | 0.0% | |
$66.3B | 6.1 | $262.7 15.0% undervalued | (1.4%) | $20.6B | $2,936.0M | 5.9% | 14.2% | 59.4% | 5.4% | 55.9% | |
$46.6B | 6.4 | $81.3 13.6% overvalued | 9.9% | $9,926.1M | $608.0M | 3.6% | 6.1% | 55.6% | 9.1% | 23.8% | |
$18.6B | 5.8 | $92.7 1.2% undervalued | (10.8%) | $3,895.4M | $288.1M | 8.4% | 7.4% | 62.8% | 5.9% | 32.0% | |
$17.9B | 4.7 | $52.7 51.1% undervalued | (16.2%) | $12.9B | $566.0M | (14.0%) | 4.4% | 37.1% | (1.5%) | 191.5% | |
$16.9B | 6.1 | $152.8 33.0% overvalued | (36.3%) | $2,893.1M | $276.4M | (1.9%) | 9.6% | 34.6% | 18.6% | 11.3% | |
$14.7B | 7.3 | $131.7 108.2% undervalued | (15.2%) | $4,038.9M | $1,135.5M | 1.8% | 28.1% | 56.2% | 13.2% | 1.0% | |
$10.4B | 5.2 | $139.9 26.6% overvalued | 50.3% | $2,094.4M | $145.3M | 2.3% | 6.9% | 48.0% | (14.8%) | 69.2% | |
$9,757.8M | 6.5 | $174.5 19.0% undervalued | 4.2% | $3,582.9M | $349.2M | 2.7% | 9.7% | 48.7% | 12.0% | 27.7% | |
$8,979.7M | 5.9 | $29.8 80.8% overvalued | (20.6%) | $616.0M | $131.3M | (8.0%) | 21.3% | 46.9% | (1.2%) | 33.3% |
FAQ
What is ResMed Inc. (RMD) stock rating?
As of today, ResMed Inc. has a stock rating of 8 (out of 10), which is considered Great.
is ResMed Inc. (RMD) a good stock to buy?
As of today, ResMed Inc. has a Great stock rating, which is 18.2% overvalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 0.5%.